iShares S&P Global Healthcare (IXJ)

Add to Watchlists
Create an Alert
101.80 +0.59  +0.58% NYSE Arca Sep 27, 16:59 Delayed 2m USD
View Full Chart
IXJ Price Chart

IXJ Key Stats

Expense Ratio 0.47%
Share Class Assets Under Management 1.571B
30-Day Average Daily Volume Upgrade
Net Asset Value 101.35
Discount or Premium to NAV -0.14%
Turnover Ratio 5.00
View All IXJ News

IXJ News

IXJ Asset Allocation

Type % Net % Long % Short
Cash 0.28% 0.28% 0.00%
Stock 99.72% 99.72% 0.00
Bond 0.00 0.00 0.00
Convertible 0.00 0.00 0.00
Preferred 0.00 0.00 0.00
Other 0.00 0.00 0.00
As of Sept. 22, 2016

IXJ Net Fund Flows

1M -10.37M
3M 49.30M
6M -35.76M
YTD 124.55M
1Y -10.78M
3Y 498.98M
5Y 615.12M
10Y 568.73M
As of Aug. 31, 2016

IXJ Net Share Class Flows

1M -10.37M
3M 49.30M
6M -35.76M
YTD 124.55M
1Y -10.78M
3Y 498.98M
5Y 615.12M
10Y 568.73M
As of Aug. 31, 2016

IXJ Region Exposure

Americas 69.09%
North America 69.09%
Latin America 0.00
Greater Europe 24.28%
United Kingdom 4.92%
Europe Developed 19.37%
Europe Emerging 0.00
Africa/Middle East 0.00
Greater Asia 6.63%
Japan 5.26%
Australasia 1.37%
Asia Developed 0.00
Asia Emerging 0.00
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00
As of Sept. 22, 2016
Region breakdown data is calculated by using the long position holdings of the portfolio.

IXJ Stock Sector Exposure

Basic Materials 0.24%
Communication Services 0.00
Consumer Cyclical 0.00
Consumer Defensive 0.00
Energy 0.00
Financial Services 0.00
Healthcare 97.76%
Industrials 1.13%
Real Estate 0.00
Technology 0.86%
Utilities 0.00
As of Sept. 22, 2016

IXJ Stock Market Capitalization

Giant 65.71%
Large 29.15%
Medium 5.14%
Small 0.00
Micro 0.00
As of Sept. 22, 2016

IXJ Stock Style Exposure

Large Cap Value 11.07%
Large Cap Blend 36.61%
Large Cap Growth 47.18%
Mid Cap Value 0.37%
Mid Cap Blend 2.75%
Mid Cap Growth 2.02%
Small Cap Value 0.00
Small Cap Blend 0.00
Small Cap Growth 0.00
As of Sept. 22, 2016
View More Holdings

IXJ Top 10 Holdings

Symbol Name % Weight Price % Chg
JNJ Johnson & Johnson 7.83% 119.46 +1.43%
NVSEF Novartis AG 5.16% -- --
PFE Pfizer Inc 4.96% 33.78 +0.42%
RHHVF Roche Holding AG Dividend Right Cert. 4.27% -- --
MRK Merck & Co Inc 4.18% 62.57 +0.68%
UNH UnitedHealth Group Inc 3.22% 140.80 +0.77%
AMGN Amgen Inc 3.15% 171.57 -1.13%
MDT Medtronic PLC 2.91% 86.66 +0.12%
GILD Gilead Sciences Inc 2.58% 79.30 -1.64%
ABBV AbbVie Inc 2.54% 64.57 +0.78%
As of Sept. 22, 2016
Advertisement

One Page Reports

IXJ Basic Info

Style
Equity Style Large Cap/Growth
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Health
Fund Owner Firm Name iShares
Benchmark Index
S&P Global 1200 Healthcare Sector NR USD
 100.0%

IXJ Manager Info

Name Tenure
Alan Mason 0.38 yrs
Diane Hsiung 8.67 yrs
Greg Savage 8.67 yrs
Jennifer Hsui 4.09 yrs

IXJ Risk Info

Beta 0.7949
Max Drawdown (All) 42.81%
Historical Sharpe (10Y) 0.6197
Historical Sortino (All) 0.649
30-Day Rolling Volatility 11.79%
Daily Value at Risk (VaR) 1% (All) 3.11%
Monthly Value at Risk (VaR) 1% (All) 11.90%

IXJ Fundamentals

Dividend Yield TTM (9-27-16) 2.33%
Weighted Average PE Ratio 23.21
Weighted Average Price to Sales Ratio 2.092
Weighted Average Price to Book Ratio 3.605
Weighted Median ROE 21.17%
Weighted Median ROA 8.47%
Forecasted Dividend Yield 2.10%
Forecasted PE Ratio 20.13
Forecasted Price to Sales Ratio 2.014
Forecasted Price to Book Ratio 3.161
Number of Holdings 107
As of Sept. 22, 2016

IXJ Growth Estimates

Forecasted 5 Yr Earnings Growth 8.87%
Forecasted Book Value Growth 9.06%
Forecasted Cash Flow Growth 6.39%
Forecasted Earnings Growth 6.02%
Forecasted Revenue Growth 9.04%
As of Sept. 22, 2016

IXJ Performance

  Returns Total Returns
1M -0.30% -0.30%
3M 4.44% 4.44%
6M 5.91% 6.89%
1Y 1.59% 4.62%
3Y 27.31% 34.63%
5Y 93.70% 114.0%
As of Sept. 26, 2016

IXJ Comparables

Edit
IHI iShares Dow Jones US Medical Devices
IYH iShares Dow Jones US Healthcare
PJP PowerShares Dynamic Pharmaceuticals
VHT Vanguard Health Care ETF
XLV Health Care Select Sector SPDR
FTXH First Trust Nasdaq Pharmaceuticals ETF

IXJ Attributes

Key Dates
Inception Date 11/13/2001
Last Annual Report Date 3/31/2016
Last Prospectus Date 8/1/2016
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

IXJ Excel Add-In Codes

  • Name: =YCI("IXJ","name")
  • Broad Asset Class: =YCI("IXJ", "broad_asset_class")
  • Broad Category: =YCI("IXJ", "broad_category_group")
  • Prospectus Objective: =YCI("IXJ", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.